Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Peter Stephens.

Newcastle AuthorsTitleYearFull text
Dr Peter Stephens
Professor Nicola Curtin
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer2016
Dr Peter Stephens
Professor Ruth Plummer
Professor Nicola Curtin
mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition2016
Professor Ruth Plummer
Dr Nicola Cresti
Dr Yvette Drew
Dr Peter Stephens
Dr Jared Thornton
et al.
Phase 1 study of the PARP inhibitor E7449 as a single agent in patients with advanced solid tumors or B-cell lymphoma2014
Dr Jane Margetts
Dr Yvette Drew
Dr Peter Stephens
Professor Alan Calvert
Professor Ruth Plummer
et al.
Erratum to: Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors (vol 31, pg 623, 2013 Doi: 10.1007/s10637-012-9843-5)2013
Dr Tao Chen
Dr Peter Stephens
Fiona Middleton
Professor Nicola Curtin
Targeting the S and G2 checkpoint to treat cancer2012
Dr Peter Stephens
Professor Alan Calvert
Professor Ruth Plummer
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors2010
Dr Peter Stephens
Cancer in the older person2008